Actively Recruiting
Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2025-02-12
25
Participants Needed
1
Research Sites
309 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation. Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients. This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.
CONDITIONS
Official Title
Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 18 years
- Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy)
- Patient who has completed adjuvant treatment, except for hormonotherapy
- Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis
- Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field
- Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job
- Patient who signed the informed consent after informed information by her clinician
You will not qualify if you...
- Metastatic breast cancer or any other cancer within the last 5 years
- Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy)
- Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder (American Psychiatric Association, 1994) Sheehan et al., 1998) with the patient's refusal of adequate psychiatric treatment (medicated or not) at the time of inclusion in the study
- Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test)
- Physical inability to answer questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut du Cancer de Montpellier
Montpellier, France, 34298
Actively Recruiting
Research Team
J
Jean-Pierre Bleuse
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here